Biosimilar Monoclonal Antibodies in Latin America
In the last decade, the expiration of patents protecting therapeutic monoclonal antibodies opened an opportunity for the development and approval of biosimilar versions of these drugs. The complexity of these biologic molecules required the imposition of strict regulations to establish robust compar...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2021
|
| Subjects: | |
| Online Access: | https://www.intechopen.com/chapters/79577 |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Biosimilar Monoclonal Antibodies in Latin America
- Monoclonal Antibodies for Cancer Treatment
- The Modern Age of Monoclonal Antibodies: The Revolution of Daratumumab
- Application of Monoclonal Antibody Therapies in Autoimmune Diseases
- Monoclonal Antibody Therapy of T-Cell Leukemia and Lymphoma
- Introduction on Monoclonal Antibodies
- Quality Control by Immunoaffinity Concentration Using Monoclonal Antibody